Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.
International News Portal
Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.
Railroad and agricultural industry leaders share concerns about Congressional proposals they say could harm freight rail and the U.S. farm economy.
StopAntisemitism founder says extremist influencers across the political spectrum are normalizing antisemitism and violence, reshaping American politics and eroding moral boundaries.
Jeffrey Towers, charged with manslaughter in the shooting death of Auburn graduate Whitney Robeson, now faces a wrongful death lawsuit from her parents.
Listen to a recap of the top stories of the day from 9to5Mac. 9to5Mac Daily is available on iTunes and Apple’s Podcasts app, Stitcher, TuneIn, Google Play, or through our dedicated RSS feed for Overca...